In new independent research reports released early this morning,
Market Source Research released its latest key findings for all
current investors, traders, and shareholders of TiVo Corporation
(NASDAQ:TIVO), Eli Lilly and Company (NYSE:LLY), Rigel
Pharmaceuticals, Inc. (NASDAQ:RIGL), SpartanNash Company
(NASDAQ:SPTN), Nustar GP Holdings, LLC (NYSE:NSH), and Hornbeck
Offshore Services (NYSE:HOS), including updated fundamental
summaries, consolidated fiscal reporting, and fully-qualified
certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available
to readers at the links below.
TIVO DOWNLOAD:
http://MarketSourceResearch.com/register/?so=TIVO
LLY DOWNLOAD:
http://MarketSourceResearch.com/register/?so=LLY
RIGL DOWNLOAD:
http://MarketSourceResearch.com/register/?so=RIGL
SPTN DOWNLOAD:
http://MarketSourceResearch.com/register/?so=SPTN
NSH DOWNLOAD:
http://MarketSourceResearch.com/register/?so=NSH
HOS DOWNLOAD:
http://MarketSourceResearch.com/register/?so=HOS
(You may have to copy and paste the link into your browser and
hit the [ENTER] key)
The new research reports from Market Source
Research, available for free download at the links above, examine
TiVo Corporation (NASDAQ:TIVO), Eli Lilly and Company (NYSE:LLY),
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), SpartanNash Company
(NASDAQ:SPTN), Nustar GP Holdings, LLC (NYSE:NSH), and Hornbeck
Offshore Services (NYSE:HOS) on a fundamental level and outlines
the overall demand for their products and services in addition to
an in-depth review of the business strategy, management discussion,
and overall direction going forward. Several excerpts from the
recently released reports are available to today's readers
below.
-----------------------------------------
Important Notice: the following
excerpts are not designed to be standalone summaries and as such,
important information may be missing from these samples. Please
download the entire research report, free of charge, to ensure you
are reading all relevant material information. All information in
this release was accessed November 30th, 2017. Percentage
calculations are performed after rounding. All amounts in millions
(MM), except per share amounts.
-----------------------------------------
TiVo CORPORATION (TIVO)
REPORT OVERVIEW
TiVo's Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, TiVo reported revenue of $197.90MM vs
$153.12MM (up 29.24%) and basic earnings per share -$0.14 vs $0.55.
For the twelve months ended December 31st, 2016 vs December 31st,
2015, TiVo reported revenue of $649.09MM vs $526.27MM (up 23.34%)
and basic earnings per share $0.35 vs -$0.05. TiVo is expected to
report earnings on February 21st, 2018. The report will be for the
fiscal period ending December 31st, 2017. The reported EPS for the
same quarter last year was $0.36. The estimated EPS forecast for
the next fiscal year is $1.75 and is expected to report on February
21st, 2018.
To read the full TiVo Corporation (TIVO) report, download it
here:
http://MarketSourceResearch.com/register/?so=TIVO
-----------------------------------------
ELI LILLY AND COMPANY (LLY) REPORT
OVERVIEW
Eli Lilly's Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Eli Lilly reported revenue of $5,658.00MM
vs $5,191.70MM (up 8.98%) and basic earnings per share $0.53 vs
$0.74 (down 28.38%). For the twelve months ended December 31st,
2016 vs December 31st, 2015, Eli Lilly reported revenue of
$21,222.10MM vs $19,958.70MM (up 6.33%) and basic earnings per
share $2.59 vs $2.27 (up 14.10%). Eli Lilly is expected to report
earnings on January 30th, 2018. The report will be for the fiscal
period ending December 31st, 2017. The reported EPS for the same
quarter last year was $0.95. The estimated EPS forecast for the
next fiscal year is $4.64 and is expected to report on January
30th, 2018.
To read the full Eli Lilly and Company (LLY) report, download it
here:
http://MarketSourceResearch.com/register/?so=LLY
-----------------------------------------
RIGEL PHARMACEUTICALS, INC. (RIGL)
REPORT OVERVIEW
Rigel Pharmaceuticals' Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Rigel Pharmaceuticals reported revenue of
$0.90MM vs $3.76MM (down 76.06%) and basic earnings per share
-$0.14 vs -$0.24. For the twelve months ended December 31st, 2016
vs December 31st, 2015, Rigel Pharmaceuticals reported revenue of
$20.38MM vs $28.90MM (down 29.46%) and basic earnings per share
-$0.73 vs -$0.58. Rigel Pharmaceuticals is expected to report
earnings on March 6th, 2018. The report will be for the fiscal
period ending December 31st, 2017. The reported EPS for the same
quarter last year was -$0.16. The estimated EPS forecast for the
next fiscal year is -$0.49 and is expected to report on March 6th,
2018.
To read the full Rigel Pharmaceuticals, Inc. (RIGL) report,
download it here:
http://MarketSourceResearch.com/register/?so=RIGL
-----------------------------------------
SPARTANNASH COMPANY (SPTN) REPORT
OVERVIEW
SpartanNash's Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, SpartanNash reported revenue of
$1,906.64MM vs $1,800.09MM (up 5.92%) and basic earnings per share
-$3.32 vs $0.44. For the twelve months ended December 31st, 2016 vs
December 31st, 2015, SpartanNash reported revenue of $7,734.60MM vs
$7,651.97MM (up 1.08%) and basic earnings per share $1.52 vs $1.67
(down 8.98%). SpartanNash is expected to report earnings on
February 28th, 2018. The report will be for the fiscal period
ending December 31st, 2017. The reported EPS for the same quarter
last year was $0.53. The estimated EPS forecast for the next fiscal
year is $2.21 and is expected to report on February 28th, 2018.
To read the full SpartanNash Company (SPTN) report, download it
here:
http://MarketSourceResearch.com/register/?so=SPTN
-----------------------------------------
NUSTAR GP HOLDINGS, LLC (NSH) REPORT
OVERVIEW
Nustar GP's Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Nustar GP reported revenue of $12.18MM vs
$16.13MM (down 24.51%) and basic earnings per share $0.26 vs $0.40
(down 35.00%). For the twelve months ended December 31st, 2016 vs
December 31st, 2015, Nustar GP reported revenue of $56.10MM vs
$79.67MM (down 29.59%) and basic earnings per share $1.28 vs $1.68
(down 23.81%). Nustar GP is expected to report earnings on January
30th, 2018. The report will be for the fiscal period ending
December 31st, 2017. The reported EPS for the same quarter last
year was $0.14. The estimated EPS forecast for the next fiscal year
is $1.34 and is expected to report on January 30th, 2018.
To read the full Nustar GP Holdings, LLC (NSH) report, download
it here:
http://MarketSourceResearch.com/register/?so=NSH
-----------------------------------------
HORNBECK OFFSHORE SERVICES (HOS)
REPORT OVERVIEW
Hornbeck Offshore Services' Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Hornbeck Offshore Services reported
revenue of $53.67MM vs $51.93MM (up 3.35%) and basic earnings per
share -$0.51 vs -$0.45. For the twelve months ended December 31st,
2016 vs December 31st, 2015, Hornbeck Offshore Services reported
revenue of $224.30MM vs $476.07MM (down 52.89%) and basic earnings
per share -$1.76 vs $1.87. Hornbeck Offshore Services is expected
to report earnings on February 21st, 2018. The report will be for
the fiscal period ending December 31st, 2017. The reported EPS for
the same quarter last year was -$0.53. The estimated EPS forecast
for the next fiscal year is -$2.72 and is expected to report on
February 21st, 2018.
To read the full Hornbeck Offshore Services (HOS) report,
download it here:
http://MarketSourceResearch.com/register/?so=HOS
-----------------------------------------
ABOUT MARKET SOURCE
RESEARCH
Market Source Research delivers the key research
reports that help serious investors, registered brokers,
professional traders, and personal investment advisers find
reliable information in today's markets. Market Source Research's
team is comprised of financial professionals, many of which hold
Chartered Financial Analyst® (CFA®) designations and FINRA®
BrokerCheck® certifications. Whether identifying emerging trends,
or discovering new opportunity, the team at Market Source Research
is dedicated to providing accurate, informative, and objective
content that’s ahead of the curve. With insights on individual
companies as well as sectors, readers get the industry's best
available combination of big-picture perspective as well as
granular detail.
REGISTERED MEMBER STATUS
Market Source Research's oversight and audit
staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and
Compliance departments. Market Source Research's roster includes
qualified CFA® charterholders, licensed securities attorneys, and
registered FINRA® members holding duly issued CRD® numbers. Current
licensed status of several Registered Members at Market Source
Research have been independently verified by an outside audit firm,
including policy and audit records duly executed by Registered
Members. Complaints, concerns, questions, or inquiries regarding
this release should be directed to Market Source Research's
Compliance department by Phone, at +1 (704) 343-6361, or by E-mail
at compliance@MarketSourceResearch.com.
LEGAL NOTICES
Information contained herein is not an offer or
solicitation to buy, hold, or sell any security. Market Source
Research, Market Source Research members, and/or Market Source
Research affiliates are not responsible for any gains or losses
that result from the opinions expressed. Market Source Research
makes no representations as to the completeness, accuracy, or
timeliness of the material provided and all materials are subject
to change without notice. Market Source Research has not been
compensated for the publication of this press release by any of the
above mentioned companies. Market Source Research is not a
financial advisory firm, investment adviser, or broker-dealer, and
does not undertake any activities that would require such
registration. For our full disclaimer, disclosure, and terms of
service please visit our website.
Media Contact: Hugo Moreau, Media Department
Office: +1 (704) 343-6361 E-mail:
media@MarketSourceResearch.com
© 2017 Market Source Research. All Rights Reserved. For
republishing permissions, please contact a partner network manager
at partnership@MarketSourceResearch.com.
CFA® and Chartered Financial Analyst® are registered
trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks
owned by Financial Industry Regulatory Authority, Inc.
TiVo (NASDAQ:TIVO)
Historical Stock Chart
From Sep 2024 to Oct 2024
TiVo (NASDAQ:TIVO)
Historical Stock Chart
From Oct 2023 to Oct 2024